Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder
NCT01837797Phase 3Terminated
- Sponsor
- Lundbeck
- Start
- Apr 2013
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of brexpiprazole orally disintegrating tablet in major depressive disorder (MDD), sponsored by Lundbeck. Started Apr 2013; status: terminated.
02
Drugs
brexpiprazole orally disintegrating tablet
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01837797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01837797.